AlTi Global Inc. Buys 14,982 Shares of KKR & Co. Inc. (NYSE:KKR)

AlTi Global Inc. raised its stake in shares of KKR & Co. Inc. (NYSE:KKR) by 564.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 17,634 shares of the asset manager’s stock after acquiring an additional 14,982 shares during the quarter. AlTi Global Inc.’s holdings in KKR & Co. Inc. were worth $1,856,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Versant Capital Management Inc lifted its holdings in shares of KKR & Co. Inc. by 622.9% during the 2nd quarter. Versant Capital Management Inc now owns 253 shares of the asset manager’s stock valued at $27,000 after purchasing an additional 218 shares during the last quarter. Mather Group LLC. lifted its holdings in shares of KKR & Co. Inc. by 371.4% during the 2nd quarter. Mather Group LLC. now owns 264 shares of the asset manager’s stock valued at $27,000 after purchasing an additional 208 shares during the last quarter. Riverview Trust Co purchased a new stake in shares of KKR & Co. Inc. during the 1st quarter valued at $27,000. American National Bank lifted its holdings in shares of KKR & Co. Inc. by 202.6% during the 2nd quarter. American National Bank now owns 351 shares of the asset manager’s stock valued at $37,000 after purchasing an additional 235 shares during the last quarter. Finally, Y.D. More Investments Ltd purchased a new stake in shares of KKR & Co. Inc. during the 2nd quarter valued at $38,000. Institutional investors own 76.26% of the company’s stock.

KKR & Co. Inc. Stock Performance

NYSE KKR opened at $131.67 on Thursday. The stock has a 50-day simple moving average of $119.88 and a two-hundred day simple moving average of $108.55. The firm has a market capitalization of $116.85 billion, a P/E ratio of 29.52, a PEG ratio of 1.11 and a beta of 1.62. KKR & Co. Inc. has a fifty-two week low of $53.72 and a fifty-two week high of $134.85. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.07 and a current ratio of 0.07.

KKR & Co. Inc. (NYSE:KKR) last posted its earnings results on Wednesday, July 31st. The asset manager reported $1.09 EPS for the quarter, beating analysts’ consensus estimates of $0.89 by $0.20. KKR & Co. Inc. had a return on equity of 5.05% and a net margin of 17.99%. The firm had revenue of $4.17 billion for the quarter, compared to analysts’ expectations of $1.07 billion. During the same period last year, the firm earned $0.58 EPS. On average, equities analysts forecast that KKR & Co. Inc. will post 3.99 earnings per share for the current year.

KKR & Co. Inc. Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, August 27th. Stockholders of record on Monday, August 12th were given a dividend of $0.175 per share. This represents a $0.70 dividend on an annualized basis and a dividend yield of 0.53%. The ex-dividend date of this dividend was Monday, August 12th. KKR & Co. Inc.’s dividend payout ratio (DPR) is presently 15.70%.

Insider Activity

In other news, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of the firm’s stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $25.75, for a total transaction of $149,350,000.00. Following the sale, the insider now directly owns 25,260,971 shares in the company, valued at approximately $650,470,003.25. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, major shareholder Kkr Group Partnership L.P. acquired 11,619,998 shares of the stock in a transaction that occurred on Wednesday, September 11th. The shares were bought at an average cost of $11.13 per share, for a total transaction of $129,330,577.74. Following the acquisition, the insider now owns 92,959,984 shares in the company, valued at approximately $1,034,644,621.92. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of KKR & Co. Inc. stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $25.75, for a total value of $149,350,000.00. Following the completion of the sale, the insider now owns 25,260,971 shares in the company, valued at $650,470,003.25. The disclosure for this sale can be found here. Insiders own 39.34% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently commented on KKR shares. Citigroup increased their price objective on KKR & Co. Inc. from $130.00 to $150.00 and gave the company a “buy” rating in a report on Friday, August 2nd. Keefe, Bruyette & Woods restated an “outperform” rating and issued a $144.00 target price (up previously from $125.00) on shares of KKR & Co. Inc. in a research note on Thursday, August 1st. Deutsche Bank Aktiengesellschaft raised their target price on KKR & Co. Inc. from $128.00 to $141.00 and gave the stock a “buy” rating in a research note on Thursday, August 1st. Redburn Atlantic assumed coverage on KKR & Co. Inc. in a research note on Tuesday, August 27th. They issued a “buy” rating and a $153.00 target price for the company. Finally, Argus upgraded KKR & Co. Inc. to a “strong-buy” rating in a research note on Thursday, August 1st. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $128.27.

KKR & Co. Inc. Company Profile

KKR & Co Inc is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market and middle market investments.